capecitabine has been researched along with Multiple Primary Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Que, SKT; Schmults, CD; Zwald, FO | 1 |
| Kakizawa, N; Kato, T; Noda, H; Rikiyama, T; Toyama, N; Watanabe, F | 1 |
| Hanyu, T; Ichikawa, H; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Koyama, Y; Minagawa, M; Nakano, M; Sakata, J; Shimada, Y; Tanaka, R; Wakai, T | 1 |
| Ayez, N; Eggermont, AM; Grünhagen, DJ; Rothbarth, J; van der Stok, EP; van Meerten, E; Verhoef, C | 1 |
| Bu, Z; Fan, B; Ji, J; Li, S; Li, Z; Ren, H; Shan, F; Tang, L; Wu, A; Wu, X; Zhang, L; Zong, X | 1 |
| Clemens, MR; Darb-Esfahani, S; Denkert, C; Diebold, K; Dietrich, K; Eidtmann, H; Hanusch, C; Henschen, S; Hoffmann, G; Holms, F; Huober, J; Just, M; Loibl, S; Schrader, I; Solbach, C; Tesch, H; Tiemann, K; Untch, M; von Minckwitz, G | 1 |
| Benekli, M; Berk, V; Buyukberber, S; Cetin, B; Coskun, U; Isikdogan, A; Kaplan, MA; Ozkan, M; Tufan, G | 1 |
| Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tani, S; Tani, T | 1 |
1 review(s) available for capecitabine and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Capecitabine; Carcinoma, Squamous Cell; Chemoprevention; Chemotherapy, Adjuvant; ErbB Receptors; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymph Nodes; Lymphatic Metastasis; Molecular Targeted Therapy; Neoplasm Staging; Neoplasms, Multiple Primary; Organ Transplantation; Programmed Cell Death 1 Receptor; Radiotherapy, Adjuvant; Sirolimus; Skin Neoplasms | 2018 |
7 other study(ies) available for capecitabine and Multiple Primary Neoplasms
| Article | Year |
|---|---|
[Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Oxaloacetates; Peritoneal Neoplasms; Recurrence | 2014 |
[A case of early gastric cancer completely responding to adjuvant chemotherapy for advanced colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms | 2014 |
The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Digestive System Surgical Procedures; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Prognosis; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome | 2015 |
Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Carcinoma, Small Cell; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Paclitaxel; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate | 2015 |
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials, Phase III as Topic; Cyclophosphamide; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome | 2012 |
Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Prognosis; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult | 2013 |
[A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX treatment, good quality of life].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Intraoperative Complications; Male; Myocardial Infarction; Neoplasms, Multiple Primary; Oxaloacetates; Quality of Life; Rectal Neoplasms; Salvage Therapy; Urinary Bladder Neoplasms | 2013 |